Chester Stanley Zygmont III

Chester Stanley Zygmont III discloses dealings in Revelation Biosciences, Inc. to SEC (Form 4). We count 8 filings; the first trade dates from 11 February 2025 and the latest from 17 August 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 18 August 2026: a share grant, in Revelation Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.